| Characteristic |
|
| Median survival (n=15 ) |
16.6 months |
| Overall survival (n=15) |
| 12-month |
80% |
| 18-month |
46.6% |
|
24-month |
20% |
| Follow up of overall group (n=15) in months |
| Mean |
19.0 |
| Median |
16.6 |
|
Range |
4.8-42.8 |
| Follow-up of surviving patients (n=4) in months |
| Mean |
29.3 |
| Median |
26.1 |
|
Range |
22-42.8 |
| Status at last follow-up (n=15) |
| Alive with disease |
02 (13.3%) |
| Alive without disease |
02 (13.3%) |
|
Died |
11 (73.3%) |
|
